Dorothy Pan, MD, 315 464-8668

Dorothy Pan, MD
Appointed 08/01/11
Women's Health Network
2275 Regional Oncology Center
750 East Adams Street
Syracuse, NY 13210

315 464-8668

Current Appointments

Hospital Campus

  • Downtown

Clinical Section Affiliations

  • Medicine: Hematology and Oncology
  • Upstate Cancer Center: Medical Oncology


Education & Fellowships

  • Fellowship: Memorial Sloan-Kettering Cancer Center, 2001, Medical Oncology and Hematology
  • Residency: Albert Einstein/Montefiore Medical Center, 1998, Internal Medicine
  • MD: Cornell University Medical College, 1995
  • BA: Massachusetts Institute of Technology, 1991

Clinical Trials

  • A Phase II Study of PNT2258 in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Read more
  • CALGB 50801-Phase II Trial of Response-Adapted Therapy Based on Positron Emission Tomography (PET) for Bulky Stage I And Stage II Classical Hodgkin Lymphoma (HL)
    Read more
  • CALGB 50904-A Randomized Phase II Trial of Ofatumumab and Bendamustine vs. Ofatumumab, Bortezomib (NSC # 681239, IND # 58443) and Bendamustine in Patients With Untreated Follicular Lymphoma
    Read more
  • Celgene Protocol Number: CC-5013-NHL-007 - A phase 3, double-blind randomized study to compare the efficacy and safety of rituximab plus lenalidomide (cc-5013) versus rituximab plus placebo in subjects with relapsed/refractory indolent lymphoma
    Read more
  • IPI-145-08: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of IPI-145 in Combination with Rituximab vs Rituximab in Subjects with Previously Treated Follicular Lymphoma
    Read more

Specialties & Certification

  • Medical Oncology
  • Hematology

Diseases & Conditions Treated

  • All Cancers and Hematological Conditions


  • Adults


  • Chemotherapy
  • Immunotherapy

Current Hospital Privileges

  • Upstate University Hospital
  • Crouse Hospital
Clinical Profile Shortcut:
Faculty Profile Shortcut: